Fate Therapeutics, Inc. (FATE) Lead Deadline Approaching: Contact Robbins LLP for Information Regarding the Class Action against Fate Therapeutics, Inc.
March 07, 2023 14:17 ET
|
Robbins LLP
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired shares...
Fate Therapeutics, Inc. (FATE) Class Action: Contact Robbins LLP for Information Regarding the Class Action and Lead Plaintiff Deadline
February 15, 2023 14:59 ET
|
Robbins LLP
SAN DIEGO, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired shares...
Fate Therapeutics, Inc. (FATE) Class Action Alert: Contact Robbins LLP for Information Regarding the Class Action Against Fate Therapeutics, Inc.
February 09, 2023 14:46 ET
|
Robbins LLP
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired...
Fate Therapeutics, Inc. (FATE) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against Fate Therapeutics, Inc.
January 27, 2023 17:24 ET
|
Robbins LLP
SAN DIEGO, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired shares...